相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma et al.
CLINICAL CANCER RESEARCH (2019)
Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?
Reagan M. Barnett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors
J. S. K. Chan et al.
ONCOGENE (2018)
Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?
Reagan M. Barnett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer
Dai Liu et al.
ONCOIMMUNOLOGY (2018)
Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages
Yufei Zhang et al.
BIOMACROMOLECULES (2018)
LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment
Rong Fu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Mary E. Klein et al.
CANCER CELL (2018)
Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts
Ying Liu et al.
CANCER LETTERS (2018)
Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance
Sana Hibino et al.
CANCER RESEARCH (2018)
Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
Binghe Tan et al.
CANCER RESEARCH (2018)
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
Tamer B. Shabaneh et al.
CANCER RESEARCH (2018)
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Joerg Huelsken et al.
CELL (2018)
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Xuexiang Du et al.
CELL RESEARCH (2018)
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8(+) T-Cell-Driven Antitumor Immunity
Sarah L. Buchan et al.
CLINICAL CANCER RESEARCH (2018)
Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients
Zhuqing Liu et al.
CLINICAL CANCER RESEARCH (2018)
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
Yee Sun Tan et al.
CLINICAL CANCER RESEARCH (2018)
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment
Takuya Kato et al.
CLINICAL CANCER RESEARCH (2018)
T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
Jiemiao Hu et al.
CLINICAL CANCER RESEARCH (2018)
Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
Ji-Chang Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice
Ghasem Ghalamfarsa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Human hepatocellular carcinoma: Protection by melatonin
Keywan Mortezaee
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
Eric Ubil et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Wenquan Ou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Emerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer
K. A. Alamoud et al.
JOURNAL OF DENTAL RESEARCH (2018)
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Qian Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation
Dinesh K. Ahirwar et al.
ONCOGENE (2018)
Intermittent hypoxia induces a metastatic phenotype in breast cancer
Anna Chen et al.
ONCOGENE (2018)
Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway
Ang Li et al.
ONCOGENE (2018)
A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment
Ameet A. Chimote et al.
SCIENCE SIGNALING (2018)
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Jennifer L. Guerriero
TRENDS IN MOLECULAR MEDICINE (2018)
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophagemediated immunotherapy
Pengfei Zhao et al.
CHEMICAL SCIENCE (2018)
Proton irradiation orchestrates macrophage reprogramming through NF kappa B signaling
Geraldine Genard et al.
CELL DEATH & DISEASE (2018)
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
Degao Chen et al.
NATURE COMMUNICATIONS (2018)
Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis
Do-Hyun Kim et al.
NATURE COMMUNICATIONS (2018)
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
Wei Xiang et al.
NATURE COMMUNICATIONS (2018)
Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
Matthew A. Lakins et al.
NATURE COMMUNICATIONS (2018)
PD-L1 expression in medulloblastoma: an evaluation by subgroup
Allison M. Martin et al.
Oncotarget (2018)
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
Lechuang Chen et al.
Oncotarget (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment
Arunakumar Gangaplara et al.
PLOS PATHOGENS (2018)
A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment
Ameet A. Chimote et al.
SCIENCE SIGNALING (2018)
CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
Natnaree Siriwon et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation
Cristiana Borrelli et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
Shamila D. Alipoor et al.
FRONTIERS IN IMMUNOLOGY (2018)
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
Adriana Albini et al.
FRONTIERS IN IMMUNOLOGY (2018)
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
Karin M. Knudson et al.
ONCOIMMUNOLOGY (2018)
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
Norio Chihara et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Recombinant Listeria promotes tumor rejection by CD8+ T cell-dependent remodeling of the tumor microenvironment
Weiwen Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages
Sara Donzelli et al.
BREAST CANCER RESEARCH (2018)
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
Ayman Oweida et al.
CLINICAL CANCER RESEARCH (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+T cells through targeting mTOR
Jiao Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours
G. Itoh et al.
ONCOGENE (2017)
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Florie Bertrand et al.
NATURE COMMUNICATIONS (2017)
CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes.
A. Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cardiotoxicity of immune checkpoint inhibitors
Gilda Varricchi et al.
ESMO OPEN (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A. Kansy et al.
CANCER RESEARCH (2017)
PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF
Conor J. Kearney et al.
CELL DEATH AND DIFFERENTIATION (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
Tomasz Ahrends et al.
CANCER RESEARCH (2016)
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
Elham Beyranvand Nejad et al.
CANCER RESEARCH (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential
Koen van de Ven et al.
IMMUNOTHERAPY (2015)
Mutation-Specific T Cells for Immunotherapy of Gliomas
Cornelis J. M. Melief
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8+ T cell generation
Catherine Gottschalk et al.
FRONTIERS IN IMMUNOLOGY (2015)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
Raghvendra M. Srivastava et al.
CLINICAL CANCER RESEARCH (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Julien Fourcade et al.
CANCER RESEARCH (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
Dimitra Bourboulia et al.
SEMINARS IN CANCER BIOLOGY (2010)
Profile of Tumor Antigen-Specific CD8 T Cells in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
Adam J. Gehring et al.
GASTROENTEROLOGY (2009)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
CD28 costimulation overcomes transforming growth factor-β-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack
Heike Koehler et al.
CANCER RESEARCH (2007)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells
TNJ Bullock et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
分享论文
